Ísrael - hebreska - Ministry of Health

megapharm ltd - nitisinone - קפסולה קשיחה - nitisinone 5 mg - nitisinone - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine

Ísrael - hebreska - Ministry of Health

megapharm ltd - nitisinone - קפסולה קשיחה - nitisinone 10 mg - nitisinone - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine

Ísrael - hebreska - Ministry of Health

j-c health care ltd - infliximab - אבקה להכנת תרכיז לאינפוזיה - infliximab 100.0 mg/vial - infliximab - infliximab - - adult :crohn's disease: treatment of severe active crohn's disease in patients who have not responded despite of a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant. treatment of fistulising crohn's disease in patients who have not responded despite of a full and adequate course of therapy with conventional treatment. -paediatric crohn's disease: remicade is indicated for: treatment of severe active crohn's disease in paediatric patients aged 6 to 17 years who have not responded to conventional therapy including a corticosteroid an immunomodulator and primary nutrition therapy or who are intolerant to or have contraindications for such therapies. remicade has been studied only in combination with conventional immunosuppressive therapy -ankylosing spondylitis: remicade is indicated for: treatment of ankylosing spondylitis in patients who have severe axial symptoms elevated serological markers of inflammatory activity and who have responded inadequately to conventional ther

Ísrael - hebreska - Ministry of Health

merck sharp & dohme israel ltd - posaconazole - תרכיז להכנת תמיסה לאינפוזיה - posaconazole 300 mg/vial - posaconazole

Ísrael - hebreska - Ministry of Health

neopharm (israel)1996 ltd - adalimumab - תמיסה להזרקה - adalimumab 50 mg/ml - adalimumab

Ísrael - hebreska - Ministry of Health

amgen europe b.v. - adalimumab - תמיסה להזרקה - adalimumab 50 mg / 1 ml - adalimumab

Ísrael - hebreska - Ministry of Health

padagis israel agencies ltd, israel - infliximab - תמיסה להזרקה - infliximab 120 mg/ml - infliximab

Ísrael - hebreska - Ministry of Health

j-c health care ltd - miconazole - ג'ל - miconazole 20 mg/g - miconazole - miconazole - oral mycosis (thrush) and fungal infections of the upper gastrointestinal tract. daktarin oral gel can be used for the prevention of oral thrush in patient receiving long-term treatment with antibiotics, steroids, cytotoxic and radiation therapy.

Ísrael - hebreska - Ministry of Health

teva pharmaceutical industries ltd, israel - benzoic acid; salicylic acid; tolnaftate - משחה - tolnaftate 10 mg/g; benzoic acid 60 mg/g; salicylic acid 30 mg/g - salicylic acid - salicylic acid - superficial dermatomycosis where a keratolytic effect is also required

Ísrael - hebreska - Ministry of Health

taro international ltd - fluconazole 150 mg - capsules - fluconazole - cryptococcosis. systemic candidiasis. mucosal candidiasis. vaginal candidiasis. dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and candida infections where topical therapy is considered inapproppriate due to the site, severity or extent of the infection.